imageResearch & Discovery

A Blog Devoted to UD Innovation, Excellence and Scholarship
image

Research & Discovery

A Blog Devoted to UD Innovation, Excellence and Scholarship

ABOVE: Dion Vlachos is the director of the Catalysis Center for Energy Innovation and the Allan and Myra Ferguson Professor of Chemical and Biomolecular Engineering at UD.

U.S. Department of Energy announces $12.8 million for UD-led center

The University of Delaware has won a $12.8 million, four-year funding renewal from the U.S. Department of Energy for the continued operation of the Catalysis Center for Energy Innovation (CCEI). The center involves scientists from academic institutions and national laboratories across the U.S. in developing catalytic technologies — the spurs that move chemical reactions along — for converting biomass, such as trees and grasses, into chemicals and fuels.

Since its inception as one of the nation’s Energy Frontier Research Centers in 2009, CCEI has discovered or greatly advanced processes that can produce soap, jet fuel, adhesives and many other useful products from substances typically regarded as waste.

“This is a terrific accomplishment which speaks volumes to the excellence of our Catalysis Center for Energy Innovation and its team of scientists from UD and our many collaborating institutions,” said University of Delaware President Dennis Assanis. “We congratulate this exceptional team and its leader, Professor Dion Vlachos, for their commitment to sustainability and their ingenuity in transforming non-edible biomass into useful materials for society. We look forward to more exciting developments in the years ahead.”

UD Research on Twitter

TOP STORIES

When history goes viral

UD’s Department of History is finding teachable moments in the coronavirus pandemic

John L. Anderson

UD alumnus to lead National Academy of Engineering

John L. Anderson has been elected president of influential engineering organization

NIIMBL

A NIIMBL Approach To Making Modern Medicines

Biopharmaceuticals have emerged recently and are having a revolutionary impact on vexing diseases such as cancer. The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), headquartered at the University of Delaware, is at the forefront of making medicines more accessible to Americans.